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ABSTRACT: Understanding how emerging influenza viruses
recognize host cells is critical in evaluating their zoonotic potential,
pathogenicity, and transmissibility between humans. The surface of
the influenza virus is covered with hemagglutinin (HA) proteins
that can form multiple interactions with sialic acid-terminated
glycans on the host cell surface. This multivalent binding affects
the selectivity of the virus in ways that cannot be predicted from
the individual receptor−ligand interactions alone. Here, we show
that the intrinsic structural and energetic differences between the
interactions of avian- or human-type receptors with influenza HA
translate from individual site affinity and orientation through
receptor length and density on the surface into virus avidity and
specificity. We introduce a method to measure virus avidity using
receptor density gradients. We found that influenza viruses attached stably to a surface at receptor densities that correspond to a
minimum number of approximately 8 HA−glycan interactions, but more interactions were required if the receptors were short and
human-type. Thus, the avidity and specificity of influenza viruses for a host cell depend not on the sialic acid linkage alone but on a
combination of linkage and the length and density of receptors on the cell surface. Our findings suggest that threshold receptor
densities play a key role in virus tropism, which is a predicting factor for both their virulence and zoonotic potential.
■ INTRODUCTION
Cross-species (zoonotic) transmission of viruses such as
influenza A and coronaviruses is a continuous threat to
humans.1,2 However, the determinants governing the ability of
these viruses to switch host species and potentially trigger
pandemics remain poorly understood.3 A clearer under-
standing of the mechanisms underlying virus−host interactions
at the molecular level allows for better predictions of the
threats of emerging viruses.4,5 These insights can also shed
light on other unexplained virus phenotypes, such as restricted
host ranges and varying degrees of pathogenicity.
The hemagglutinin (HA) of influenza A virus (IAV) initiates
infection by binding to sialic acid-terminated glycan receptors
on the host cell glycocalyx. Mutations in the receptor-binding
domain (RBD) of HA can lead to changes in both affinity and
specificity. These changes are associated with influenza
zoonoses,6−8 antigenic drift,9 transmissibility,10,11 and patho-
genicity.4,12 Mutations outside the RBD may influence
sialoglycan binding indirectly by adjustment of HA thermo-
stability or virus morphology.13,14
While the HA of avian IAV preferentially binds to sialic acids
linked via an α2,3-linkage to a penultimate galactose, those
adapted to humans favor the α2,6-linkage.6 The impact of
RBD mutations on receptor binding is reflected in the
orientation of these receptors in their complex with HA.15
With sialic acid in the binding pocket, the remaining glycan
residues extend in different topologies based on the α2,3- or
α2,6-linkage and interactions between the glycan and the
surface of HA.16 In avian-adapted HA subtypes, the α2,3-
glycans extend out from the RBD perpendicular to the HA
protein. In human-adapted HA subtypes, the α2,6-glycans
extend over the HA head domain.17,18
Although the monomeric solution affinity (Kd) for HA−
sialoglycan binding is typically in the millimolar range, intact
IAV can bind to cells at picomolar virus concentrations.19−22
The binding affinity is dependent on receptor density,19,20 but
the exact number of HA−sialoglycan contributions remains
unclear. Quantitative assessment of influenza interactions with
the host cell glycocalyx requires a method that deconvolutes
affinity, specificity, density dependence, and structural aspects
of influenza−glycan interactions in a representative environ-
ment, as well as a physical−mathematical model that translates
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the individual molecular determinants of the affinity and
contact area into the overall affinity and specificity. Previously,
a numerical model was applied to show that multivalent
particles that form weak receptor−ligand interactions bind to
areas of varying receptor density in a nonlinear fashion,
characterized by a threshold receptor density at which binding
becomes efficient.23
We show how intrinsic structural differences in binding of
HA to α2,3 and α2,6 receptors transfer through the length and
density of sialoglycans at the cell surface into virus avidity and
specificity. We developed a multivalent affinity platform to
probe these individual contributions in an environment that
approximates the molecular architecture of the cell membrane.
We accomplished this by creating sialoglycan receptor density
gradients on supported lipid bilayers to obtain virus threshold
receptor densities. We combine information from multiple
platforms to study the combined effects of receptor type,
density, and length on the virus binding. We developed an
analytical model to quantitatively describe binding profiles of
IAV to assess multivalent binding at the threshold density.
Finally, the molecular mechanism is further explored by
molecular dynamics simulations to provide detailed insights
into structural aspects of the binding process.
■ RESULTS AND DISCUSSION
Multivalent Affinity Profiling. To study receptor density
dependence of IAV binding, we developed multivalent affinity
profiling (MAP), a method based on the colocalization of
Figure 1. The MAP chip is a platform to quantitate IAV binding to a host cell-mimicking surface. (a) Cartoon showing how glycans immobilized
by streptavidin onto supported lipid bilayers (SLBs) were used to mimic the host cell architecture (not to scale). (b) Structure of the biotinylated
glycans. 2,3-S(LN)n are avian-type receptors and 2,6-S(LN)n human-type. (LN)2 has no sialic acid and was used to control receptor density on
QCM and BLI platforms. (c) Schematic representation of the MAP platform, where viruses only bind above the threshold receptor density for a
particular virus−sialoglycan combination. (d) Methodology to create the gradient platform and to study virus binding on receptor gradients.
Electrophoretic gradients of biotinylated lipids are formed in SLBs in a microfluidic device at elevated temperature and subsequently cooled down
to lock the gradients (i). The biotin gradient is modified with fluorescently labeled streptavidin (SA) and biotinylated sialoglycans (ii). The
fluorescently labeled influenza virus is passed over the SLBs with the sialoglycans acting as receptors (iii). (e) Cartoons showing how length and
linkage of the sialoglycans can affect virus binding in the case of PR8. The contact area is indicated in peach. If both receptor length and linkage
(2,3 or 2,6) are favorable, the virus binds at high and low receptor density (i). If linkage is unfavorable (ii), PR8 may still bind at high and low
densities. Other influenza viruses may show a stronger preference for one receptor type and bind only at high densities. If length is unfavorable (iii),
the virus binds only at high receptor density. If both are unfavorable, the virus may not bind at all (iv).
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fluorescently labeled viruses and receptors on broad-range and
continuous surface gradients. We applied this method to study
the binding of IAV as a function of receptor density using
glycans with different lengths and linkages. To mimic the
presentation of glycans on a cell surface, we use biotinylated
glycans immobilized by streptavidin (SA) on a supported lipid
bilayer (SLB) (Figure 1a). The glycans consist of sialic acid
α2,3- or α2,6-linked to one, two, or three N-acetyl lactosamine
repeats (2,3- or 2,6-S(LN)n, Figure 1b). They are presented in
a density gradient to visualize the threshold receptor density,
above which viruses bind with maximum coverage, and with
negligible coverage below (Figure 1c).23,24 This threshold
receptor density is the key indicator of virus binding specificity
in the MAP platform.
The MAP chip gradients are formed in a microfluidic device
that we developed for this purpose.25,26 First, we comixed a
charged biotinylated lipid and a zwitterionic base lipid
(MPPC) to form the SLB and subsequently subjected the
SLB to an electrical field at elevated temperature, yielding
stable surface−biotin gradients at room temperature (Figure
1d). We then functionalized the gradients of biotinylated lipids
with fluorescently labeled SA and S(LN)n and subsequently
passed fluorescently labeled IAV over these receptor gradients
and mapped the colocalization of virus and receptors to
determine the threshold receptor density. This allows us to
study the combined effect of the glycan length and 2,3- or 2,6-
linkage on the binding of influenza as a function of the receptor
density (Figure 1e).
Threshold Density Dependence on Receptor Type
and Length. To study the density-dependent binding of IAV
on different glycan types, we used UV-inactivated influenza A/
Puerto Rico/8/34 (PR8) Mount Sinai strain with fluorescent
label. The colocalization of this virus with S(LN)n receptors on
green-labeled streptavidin was imaged with fluorescence
microscopy (Figure 2a,b). While the receptors formed a
gradient with an exponential curve, the fluorescent signal of the
virus showed the characteristic sigmoidal profile (Figure 2c).
Because the average receptor density of the gradient is known,
the sigmoidal binding profile of the virus can be related to the
absolute receptor densities of 2,3- and 2,6-S(LN)n (Figure 2d).
Virus binding data from multiple pairs of micrographs were
combined to afford these binding profiles (Figures S1 and S2).
We observe for PR8 that the threshold receptor densities for
all glycans lie within the range 0.9−5.2 pmol/cm2. The longest
2,3- and 2,6-S(LN)3 glycan receptors display the lowest
binding thresholds, which are the same for both glycans
(Figure 2e). The threshold density becomes higher with
shorter glycans, but the effect is more profound for 2,6-S(LN)n
than for 2,3-S(LN)n. Analyses with quartz crystal microbalance
(QCM, Figure S3a) and biolayer interferometry (BLI, Figure
S3b) show approximately the same threshold density values,
but the binding for 2,6-S(LN)1 was too low to detect using
these techniques (Figure S3c).
Similarly, we compared the data with the binding of PR8 on
a traditional glycan array (Figure S3d). Linear S(LN)3 and
branched glycans of different lengths, each with 2,3-, 2,6-, or
without sialic acid, were immobilized on a microarray and
incubated with labeled PR8. The relative fluorescence intensity
of bound PR8 was measured. As observed for MAP, the
microarray data show that PR8 can bind to both 2,3- and 2,6-
Figure 2. Multivalent affinity measurements using different glycan receptors. (a) Fluorescence micrograph of receptor gradients with labeled SA.
(b) Fluorescence micrograph of adsorbed labeled virus, binding selectively at high receptor densities. (c) Fluorescence intensity profiles of labeled
SA (green) and virus (red) as a function of distance along the horizontal direction. The black lines show the median along the vertical direction.
The variance is given by the red and green contours which indicate the percentage of data points between each contour line and the median. (d)
Multivalent affinity profiles of influenza PR8 virus as a function of receptor density. The data to which the curves were fitted are shown in Figure S1.
(e) Threshold receptor densities for S(LN)n. Error bars show the 95% confidence interval of the fit. n.s., not significant; *, p < 0.05; ***, p < 0.001.
ACS Central Science http://pubs.acs.org/journal/acscii Research Article
https://dx.doi.org/10.1021/acscentsci.0c01175
ACS Cent. Sci. XXXX, XXX, XXX−XXX
C
linkages, and the binding to shorter glycans is lower, in
particular for 2,6-linked glycans. Interestingly, PR8 is also more
sensitive to the branching of 2,6- than of 2,3-linked glycans.
Theoretical Model to Describe the Multivalent
Binding of Influenza Virus. To understand how glycan
type and length affect the position of the threshold receptor
density, we developed a theoretical binding model, based on
the statistical thermodynamics of multivalent adsorption.23,27
In the Supporting Discussion 1 section of the Supporting
Information, we derive a theoretical expression for the
multivalent equilibrium binding constant Kav of virus particles
on a receptor surface and the average number of possible
simultaneous virus−glycan receptor interactions Ñ. The
resulting expression depends on several fundamental properties
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The following parameters are virus characteristics: the
excluded volume Vex of a virus particle, the effective
equilibrium constant of an individual HA−glycan interaction
Ki,eff (the inverse of Kd), and the RBD density on the virus
surface σL. Vexplore, Acontact, and σR are surface characteristics:
the receptor density σR, the volume accessible to a glycan
Vexplore, and the surface area that can be reached by RBDs when
the virus is bound Acontact. The quantity (1/NA Vexplore), where
NA is Avogadro’s number, is the “effective molarity” of glycan
receptors on the surface, from the perspective of a single HA
monomer on a bound virus. The effective equilibrium constant
Ki,eff can be higher than the equilibrium constant in solution
due to mass-transfer effects associated with rebinding to the
surface,28 or lower due to additional free energy costs such as
from steric repulsion between HA and the surface and any
configurational entropy cost for forming the bond.29,30
Although no significant nonspecific binding was observed in
a binding study without glycans in QCM-D (Figure S4a), the
possible effect of a nonspecific free energy contribution on the
virus binding profiles is also discussed in the Supporting
Discussion 1 section of the Supporting Information.
We applied the theoretical model to fit the binding profiles
of IAV (Figure 2d) and determine the number of interactions
needed at the threshold and Ki,eff (Supporting Discussion 1
section in the Supporting Information). Molecular dynamics
(MD) simulations were used to determine the minimum and
maximum length of each glycan and to derive Acontact and
Vexplore (Figure S5). The number of interactions at the
threshold Ñthreshold is calculated using eq 2. Because σL is on
average 3.8 pmol/cm231 and can locally be as high as 7.7 pmol/
cm2 for close-packed HA,32 σR is generally lower than σL at the
threshold density (Figure 2e). This applies even to 2,6-S(LN)1
if we assume that viruses that bound at the threshold density
used their areas with the highest HA density. Ñthreshold is
therefore the product of the threshold receptor density and
Acontact (Figure 3c). Ñthreshold is approximately 8 for S(LN)3 and
up to 29 for 2,6-S(LN)1 as shorter glycans contribute less to
the overall avidity than longer glycans (Figure 3d), thus
requiring a higher number of interactions to bind.
Molecular Modeling of HA−Glycan Binding. To
understand the influence of glycan length, structure, and
presentation on the virus binding, MD simulations were
employed to explore the possible shapes S(LN)n glycan−
linker−biotin molecules can adopt when bound to the SA
tetramer. To take into account the orientational constraints of
the HA and SA molecules that arise from their immobilization
on the virus and array surfaces, respectively, the angle between
the center lines of the HA and SA was determined (Figure 4a).
Based on a simple geometric model (Figure 4c) for a spherical
virus interacting with glycans projecting from a flat SA surface,
the allowable angular range for the glycan relative to the
surface depends on the glycan length and the virion radius.
The MD data were used to provide estimates of the average
glycan length for each type of glycan bound to SA. With these
values, the allowable angles were determined (Figure 4b;
Supporting Discussion 2 section in the Supporting Informa-
tion).
The percentage of shapes for each SA-immobilized glycan
type that could allow HA binding were determined (Figure
4b). In general, as the glycan becomes shorter, it displays fewer
shapes compatible with HA binding, particularly in the case of
2,6-S(LN)1, which correlates with the observed avidity data
(Figure 2e). The decrease in shapes compatible with HA
binding corresponds to the decrease in conformational entropy
of the glycans but ignores interactions between the HA head
and LN repeats.17 For each glycan, the total number of
orientations with allowable angles correlates well with the
observed dependence on receptor densities (Figure 2); the
shorter glycans, especially 2,6-S(LN)1, have fewer acceptable
Figure 3. Theoretical model for multivalent binding of influenza. (a)
Cartoon of a virus bound to a glycan-coated surface with model
parameters indicated. σL is the density of RBDs on the virus. Vex is the
excluded volume of a bound virus, which is a function of its diameter.
Ñ is the average number of HA−glycan interactions that can form
simultaneously. σR is the density of receptors on the surface. Acontact is
the receptor surface area that can be reached by RBDs on the virus.
(b) zoom-in of a single HA−glycan interaction. Ki,eff is the
monovalent receptor−ligand equilibrium of a surface-bound glycan
and virus-bound RBD. Vexplore is the volume accessible to a glycan. (c)
Values of Ñthreshold for different glycan types and lengths, calculated
from the threshold receptor density and maximum length of each
glycan. (d) Fitted values of Ki,eff/NAVexplore, the contribution of
individual interactions to the avidity.
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glycan poses and therefore require a higher receptor density to
bind the virus.
Because the modes of binding that are accessible are
unequally affected by glycan length, we investigated (Support-
ing Discussion 2 section in the Supporting Information) the
conditions under which (A) two glycans on different SAs could
bind to different RBDs in the same HA trimer (2 SA−1 HA),
(B) two glycans on the same SA could bind to two different
HA trimers (1 SA−2 HA), or (C) two glycans on the same SA
could bind to the same HA trimer (1 SA−1 HA). Both the 2
SA−1 HA mode and the 1 SA−2 HA mode are more
accessible for 2,3-S(LN)n glycans than for 2,6-S(LN)n and are
more strongly affected by glycan length for 2,6-S(LN)n. The
bidentate 1 SA−1 HA mode was only accessible to 2,6-S(LN)3
and not to shorter or 2,3-linked glycans, which is consistent
with the findings of Peng et al.33 and Nemanichvili et al.18 for
branched glycans.
■ DISCUSSION
Glycan structure and presentation have a profound influence
on both the monovalent and multivalent surface affinities. The
values for Ki,eff that we found for S(LN)3 (Figure S5f) are
comparable to the solution equilibrium constants that were
measured for X-31, which has HA and NA of Aichi/2/68
(H3N2) and other genes from PR8 and has highly similar
binding profiles in BLI.19,34 For S(LN)1, Ki,eff is an order of
magnitude lower, which is consistent with the fewer number of
shapes of the immobilized S(LN)1 glycan that are able to bind
to the HA. This is consistent with the increased entropic cost
of forming an S(LN)1−RBD interaction that is suggested by
MD (Figure 4b). In addition, the entropy of the multivalent
virus−surface interaction is affected by differences in the
availability of multivalent binding modes (Supporting Dis-
cussion 2 section in the Supporting Information). The 1 SA−2
HA and 2 SA−1 HA modes are both more accessible to 2,3-
than to 2,6-S(LN)n. The equally high avidity observed for 2,6-
S(LN)3 could therefore be a result of its unique ability to form
a bidentate interaction between two SA-bound glycans and a
single HA. Because all modes are less available to the shorter
2,6-S(LN)1 and 2,6-S(LN)2, their avidity is lower.
Through the length and density of glycans, their effects on
virus binding translate into different multivalent affinities and
selectivities. This is especially evident for PR8, which binds
readily to both α2,3- and α2,6-linked sialoglycans, but likely
applies also to other IAVs possessing clear specificity. The
type, length, and density dependence of these complex virus−
receptor interactions may explain why some IAVs infect certain
cell types, and others do not. For example, duck intestinal
mucosa is rich in α2,3-sialosides whereas human upper airway
tissue expresses high levels of α2,6-sialosides.35 The IAVs
circulating in humans are of avian origin and acquired the
ability to use α2,6-linked sialosides. It is becoming increasingly
clear that the glycocalyx varies considerably between (host)
species,6,36 and between different cell types.37,38 Not only
differences in α2,3- or α2,6-linkage of sialoglycans but also
their branching, the length of their branches, and the density of
sialoglycans determine to which cells IAV binds. Although
glycomic studies of human lung tissue have shown the
Figure 4. Glycan shapes and HA−SA angles that lead to binding in molecular dynamics. (a) The crystal structure of influenza HA in complex with
2,3-S(LN)1 (gray surface, binding sites in cyan) superimposed onto the biotinylated 2,3-S(LN)3 bound by SA via the penultimate Gal residue of
the glycan (shown as 3D-SNFG). This superimposition was repeated for each of the four biotinylated glycans in each glycan system, and for each
snapshot taken from the MD simulations. Any structures with atomic overlaps between the HA and SA were removed from consideration. The
angle between the two center lines of the HA and SA was measured (180° for the structure shown here). (b) Histogram plots of the frequency of
shapes that did not result in atomic overlap between HA and SA as binned every 10° of the angle between the center lines of SA and HA. The total
percentage of glycan shapes without atomic overlap and the percentage of shapes accessible if the rotations of HA and SA are restricted are shown
under each glycan structure (n = 20 000 for each system). (c) Range of acceptable angles (ϕ) between the HA axis and the normal to the flat
surface as a function of virion radius (R) and glycan length (L).
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presence of sialosides presented on extended LN moieties, the
density of functional receptors is not known, and glycan arrays
that present a variety of α2,3- and α2,6-linked sialoglycans of
varied length and branching are unable to predict infection of
human respiratory tissue.38
The total density of sialic acid in the glycocalyx of cells is
typically 10-fold higher than the threshold density on our
sensor.39,40 However, as the glycocalyx presents a dense brush
that extends approximately 1 μm from the cell surface,41 only a
small fraction of these moieties can be involved in the initial
binding of a virus so that only the density variations near the
outer surface of the glycocalyx may be involved in host cell
recognition. That the accessibility of sialoglycans is more
important than their number is supported by the observations
on human alveolar epithelial cells that IAVs associate more
strongly with the mucin MUC1 than with the much larger
MUC1642 as well as in synthetic systems where IAVs
responded to density variations of sialic acid-modified
polymers in a mucuslike brush where each polymer displayed
on average 90 sialic acid groups.43
For weaker-binding IAVs than PR8, where the threshold
receptor density would be higher than their density of RBDs,
the 3D presentation and flexibility of receptors may play a
major role in their specificity by forming sufficient interactions
only when the glycocalyx shapes itself to the virus. Most
human IAVs bind less strongly to α2,3-linked glycans than PR8
but more strongly to α2,6-linked glycans of the same length,
whereas the opposite is true for most avian IAVs, and some
such as Anhui/1/2013 (H7N9) bind less strongly to glycans of
both linkages.19,20,34,43,44 It is therefore likely that variations in
both the density and structure of sialoglycans in the glycocalyx
play a role in the host cell specificity of IAV. The preference of
IAV to bind one cell type over another was further associated
with increased airborne transmissibility11 and A/H5N1 virus
pathogenicity.37
The MAP chip and supporting model offer a method to
quantitatively characterize the multivalent binding of any virus
that binds multivalently to cellular glycan receptors. This study
shows that IAV needs a specific minimum number of RBD−
glycan pairs to form. Not only the structure of the virus but
also that of the glycans determines the density at which this
number of interactions is achieved. This way, intrinsic
structural (and energetic) differences of an α2,3- or α2,6-
linked glycan in the RBD are translated into different
multivalent binding profiles. MAP may allow studying not
only how individual RBD receptor mutations influence the Ki
but also how changes in virus morphology affect Kav. We
expect that it is through multivalency that such mutations are
associated with virus pathogenicity and transmissibility. MAP
may therefore be used in concert with quantitative glycomics
to further elucidate the connection between the multivalency
of viruses and these phenotypes in order to predict the
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